Impotence. Male erectile disorder
Conditions
Interventions
Intervention 1: Intervention group: In both groups, 10 cc of blood will be taken from the patients. Then the sample will be placed in a special centrifuge. Within minutes, the PRP portion of the blood
Arteriocyte Medical Systems, Hopkinton, MA) to yield approximately 10 mL of PRP. Specifically, PRP is automatically separated from anticoagulated whole blood in about 15 minutes and dispensed into a s
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: Men aged 40 to 70 years old Use of any phosphodiesterase type 5 inhibitor (PDE5i) within one month prior to screening Presence of mild or moderate erectile dysfunction after discontinuation of PDE5i or any other erectile dysfunction treatment Agree to have sexual intercourse at least four times a month during the study period Without being under the influence of alcohol or drugs
Exclusion criteria
Exclusion criteria: Previous major pelvic surgery or trauma Previous penile surgery or radiation therapy History of priapism, penile fracture, Peyronie's disease, penile curvature or any other anatomical disorder affecting erectile function Abnormal morning (less than 300 ng/dL or more than 1197 ng/dL) serum testosterone levels Erectile dysfunction A history of any severe medical or psychiatric illness that would interfere with participation in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| International Index of Erectile Function(IIEF) score in the IIEF questionnaire. Timepoint: It will be checked 3, 1 and 6 months after the injection. Method of measurement: International Index of Erectile Function, which evaluates men's erectile performance in 5 areas with 15 questions. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmir Hossein Eslami
Shahid Beheshti University of Medical Sciences
Outcome results
None listed